Literature DB >> 12809398

Intracardiac left ventricular support in beating heart, multi-vessel revascularization.

Frank Isgro1, Arndt H Kiessling, Erik Rehn, Johannes Lang, Werner Saggau.   

Abstract

BACKGROUND: Less invasive operation procedures without support of extracorporeal circulation are becoming increasingly important. A basic requirement for good long-term results in such cases is, however, the complete revascularization of the affected coronary vessels. The unsatisfactorily high conversion rate from bypass operations originally planned as off-pump to conventional operations with heart-lung machines, because of the failure to reach the target vessels on the rear wall of the heart through hemodynamic instability led to investigation of the efficiency of a microaxial pump (Impella elect) placed in the left ventricle.
METHODS: In a prospective project 15 of 38 consecutive patients selected for coronary revascularization with beating heart had a micro pump transaortically implanted in the left ventricle to support the heart during the operation with a flow rate of 2.5 to 3.9 l/min.
RESULTS: With 8 of 23 patients operated on without pump support, the operation had to be converted to conventional methods with a heart-lung machine. Only one patient out of the left-ventricle-supported group had to be further operated on conventionally because of a deep intramyocardial positioned left anterior descending coronary artery (LAD) (p < 0.05). The investigated laboratory parameters, especially creatine kinase (CK), CK-MB isoenzyme, and clotting showed no significant difference. There tended to be a higher blood loss recorded with the pump-supported patients.
CONCLUSION: In summary, it appeared that the application of a left ventricular coaxial pump with comparable results seemed to make possible complete revascularization in nearly all patients.

Entities:  

Mesh:

Year:  2003        PMID: 12809398     DOI: 10.1046/j.1540-8191.2003.02022.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  2 in total

1.  Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO.

Authors:  C William Heise; David Beutler; Adam Bosak; Geoffrey Orme; Akil Loli; Kimberlie Graeme
Journal:  J Med Toxicol       Date:  2015-03

2.  Initial experience covering 50 consecutive cases of large Impella implantation at a single heart centre.

Authors:  Yukiharu Sugimura; Shintaro Katahira; Moritz Benjamin Immohr; Nihat Firat Sipahi; Arash Mehdiani; Alexander Assmann; Philipp Rellecke; Igor Tudorache; Ralf Westenfeld; Udo Boeken; Hug Aubin; Artur Lichtenberg; Payam Akhyari
Journal:  ESC Heart Fail       Date:  2021-09-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.